Dare Bioscience, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Dare Bioscience, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $0.00.
- Dare Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $912.96K.
- Dare Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $81.53M, a 3562.44% increase from fiscal 2013.
- Dare Bioscience, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2013 was $2.23M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |
| 2017-12-31 | $912.96K 10-K · filed 2019-04-01 | |
| 2014-12-31 | $81.53M 10-K/A · filed 2017-06-13 | |
| 2013-12-31 | $2.23M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |